Clinical Trial Update: Clinical Investigation for Everolimus Drug Eluting Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical investigation of an everolimus-eluting stent for coronary artery disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: Frisch Medical Device Private Limited | Conditions: Coronary Arterial Disease (CAD) | Phase 4 | Status: COMPLETED | Results posted: 2026-03-11